The demand for advanced therapies has exploded. And so has the need to generate billions of viable cells necessary to take your discoveries from hopeful promise in the lab to safe, effective patient treatments for the world’s most challenging diseases. Corning partners with you from start-up to scale-up using our innovative, closed-system, adherent and suspension-based solutions to support the transition from cultures at the bench to large scale cell production.
Our expert team draws on decades of experience in cell culture and bioprocess to help you select and optimize the best technology platform to meet your production goals. We partner with you to adapt techniques, customize your process and streamline workflow. Corning supports your advanced therapies program with:
- Scale-up and Scale-out workflow design
- Optimized surface and media selection based on application
- Assistance with manufacturing processes and protocol development
- Design and implementation support for closed-system manufacturing platforms
Our broad range of cell culture systems and platform, as well as advanced surfaces are well-suited to support academic, biotech, and pharmaceutical laboratories, as well as CMOs and cell banks.